Stocks · Health care · Pharmaceutical Preparations

OCULAR THERAPEUTIX, INC

OCUL Clue Score42
United States Fiscal year ends December CIK 0001393434 Results filed 3 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Donald Notman
31 Aug 2026
Chief Operating Officer
Sell
1,099
$10.24
$11.25K
Donald Notman
12 Feb 2026
Chief Operating Officer
Sell
11,446
$9.04
$103.47K
Donald Notman
4 Feb 2026
Chief Operating Officer
Sell
6,035
$8.54
$51.54K
Donald Notman
2 Feb 2026
Chief Operating Officer
Sell
5,455
$9.14
$49.86K
Donald Notman
2 Sep 2025
See Remarks
Sell
1,066
$12.43
$13.25K
Donald Notman
4 Feb 2025
See Remarks
Sell
11,119
$7.81
$86.84K
Donald Notman
31 Jan 2025
See Remarks
Sell
6,301
$7.84
$49.40K
Antony C. Mattessich
5 Feb 2024
President and CEO
Sell
19,642
$4.86
$95.46K
Donald Notman
5 Feb 2024
Chief Financial Officer
Sell
6,212
$4.86
$30.19K
Rabia Gurses Ozden
5 Feb 2024
Chief Medical Officer
Sell
6,346
$4.86
$30.84K
Philip C. Strassburger
5 Feb 2024
General Counsel
Sell
6,029
$4.86
$29.30K
Christopher G White
5 Feb 2024
Chief Business Officer
Sell
5,910
$4.86
$28.72K
Antony C. Mattessich
31 Jan 2024
President and CEO
Sell
18,338
$4.95
$90.77K
Christopher G White
31 Jan 2024
Chief Business Officer
Sell
5,147
$4.95
$25.48K
Philip C. Strassburger
31 Jan 2024
General Counsel
Sell
6,831
$4.95
$33.81K
Rabia Gurses Ozden
31 Jan 2024
Chief Medical Officer
Sell
7,764
$4.95
$38.43K
Donald Notman
31 Jan 2024
Chief Financial Officer
Sell
6,433
$4.95
$31.84K
Rabia Gurses Ozden
7 Jul 2023
Chief Medical Officer
Sell
832
$4.93
$4.10K
Antony C. Mattessich
6 Feb 2023
President and CEO
Sell
19,669
$4.24
$83.40K
Philip C. Strassburger
6 Feb 2023
General Counsel
Sell
6,181
$4.24
$26.21K
Donald Notman
6 Feb 2023
Chief Financial Officer
Sell
6,476
$4.24
$27.46K
Rabia Gurses Ozden
6 Feb 2023
Chief Medical Officer
Sell
6,416
$4.24
$27.20K
Christopher G White
6 Feb 2023
Chief Business Officer
Sell
5,829
$4.24
$24.71K
Richard L Md Lindstrom
20 May 2021
Director
Sell
10,000
$14.30
$143.00K

What was left out

Form 4 filings counted 261
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 49
Sales straight out of an exercise 1
Sales at will 24
Transactions with no price 1
Shares from compensation/vesting 12,632,639
Sales filed before the plan box existed 6
History held since 31 Jul 2014